デフォルト表紙
市場調査レポート
商品コード
1531898

がん保険の世界市場レポート 2024年

Cancer Insurance Global Market Report 2024

出版日: | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.67円
がん保険の世界市場レポート 2024年
出版日: 2024年08月12日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

がん保険市場規模は、今後数年間で力強い成長が見込まれます。2028年には年間平均成長率(CAGR)8.2%で1,037億6,000万米ドルに成長します。高齢化、製品・サービスの進歩、経済変動、ヘルスケア政策と政策規制、啓発活動、マーケティング活動、パンデミックの影響などにより、成長が予測されます。予測期間中の主な動向としては、より広い範囲をカバーするための革新的な商品発展、個人の要件に合わせたカスタマイズ可能な保険、医療保険制度との統合や補助的なオプションとしての保険、保障内容に影響を与える技術の進歩などが挙げられます。

がん罹患者数の増加が今後のがん保険市場の成長を牽引すると予想されます。この増加の主な要因は、人口の高齢化、タバコの使用や不健康な食事などのライフスタイルの変化、汚染や発がん物質への暴露などの環境要素などです。がん保険は、通常の健康保険ではカバーできない医療費やその他の関連費用をカバーすることで、経済的な保護を提供し、がん治療に伴う多額の経済的負担に個人が対処できるよう支援します。例えば、国際がん研究機関(IARC)と米国がん協会(ACS)によると、世界のがん罹患者数は2022年に約2,000万人に達し、2050年には年間3,500万人に77%増加すると予測されています。肺がんが最も多く(12.4%)、乳がん(11.6%)、大腸がん(9.6%)と続く。死亡者数も肺がんが最も多く、180万人(18.7%)、次いで大腸がん(9.3%)、肝臓がん(7.8%)となっています。したがって、がん患者数の増加ががん保険市場の成長を後押しすると予想されます。

がん保険市場の主なプレーヤーは、女性向けに特化したがん保険保険など、革新的な保険商品の開拓に注力しており、女性特有のヘルスケアニーズに対応した個別保障を提供しています。これらの保険は、がんと診断された女性契約者特有の医療的・経済的要件に対応し、専門的な保障と支援を提供します。例えば、インドを拠点とする保険会社Elephant.inは、2024年3月に女性向けに特別に設計されたユニークながん保険保険を導入しました。この保険は、がんの診断と治療という大きな課題に直面する女性に、経済的な保障を提供することを目的としており、女性が罹患する5つの主ながん種(乳がん、子宮頸がん、卵巣がん、口腔がん、大腸がん)をカバーしています。この保険は、対象となるがんと診断された場合に一時金が支払われ、500万インドルピー(50万米ドル)から3,000万インドルピー(30万米ドル)の範囲の経済的支援を提供します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の市場規模と成長

  • 世界のがん保険市場:促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界のがん保険市場の実績:規模と成長、2018年~2023年
  • 世界のがん保険市場の予測:規模と成長、2023年~2028年、2033年

第6章 市場セグメンテーション

  • 世界のがん保険市場:タイプ別、実績と予測、2018年~2023年、2023年~2028年、2033年
  • 肺がん
  • 肝臓がん
  • 世界のがん保険市場:保険プラン別、実績と予測、2018年~2023年、2023年~2028年、2033年
  • 個人プラン
  • サプリメントプラン
  • 重大疾病プラン
  • 世界のがん保険市場:流通チャネル別、実績と予測、2018年~2023年、2023年~2028年、2033年
  • ブローカー
  • バンカシュアランス
  • エージェント
  • 直接販売
  • その他流通チャネル
  • 世界のがん保険市場:エンドユーザー別、実績と予測、2018年~2023年、2023年~2028年、2033年
  • 成人
  • 小児

第7章 地域別・国別分析

  • 世界のがん保険市場:地域別、実績と予測、2018年~2023年、2023年~2028年、2033年
  • 世界のがん保険市場:国別、実績と予測、2018年~2023年、2023年~2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • がん保険市場:競合情勢
  • がん保険市場:企業プロファイル
    • UnitedHealth Group Incorporated
    • Ping An Insurance(Group)Company of China Ltd
    • Cigna Group
    • Allianz SE
    • Legal & General Group plc

第31章 その他の大手企業と革新的企業

  • AXA SA
  • Aetna Inc
  • MetLife Inc
  • Dai-ichi Life Holdings Inc
  • Munich Re Group
  • China Pacific Life Insurance Co Ltd
  • American International Group Inc
  • Liberty Mutual Insurance Company
  • China Life Insurance Company Limited
  • Zurich Insurance Group Ltd
  • MAPFRE SA
  • Huaxia Life Insurance Co Ltd
  • Aegon NV
  • AFLAC Incorporated
  • Atlas Cancer Insurance Services Ltd

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと潜在的な分析

第36章 付録

目次
Product Code: r18809

Cancer insurance is an additional form of health coverage designed to assist with expenses arising from the diagnosis and treatment of cancer that go beyond what regular health insurance typically covers. This can encompass medical treatments, non-medical costs, income loss during treatment, and other related expenditures.

There are several types of cancer insurance, such as lung cancer and liver cancer coverage. Lung cancer insurance targets individuals specifically concerned about the risks associated with lung cancer, offering financial assistance for medical treatments, care, and associated expenses related to lung cancer diagnosis and treatment. These insurance plans are classified into individual plans, supplement plans, and critical illness plans. Distribution channels include brokers, bancassurance, agents, direct sales, and others, while the end users encompass both adults and children.

The cancer insurance market research report is one of a series of new reports from the business research company that provides cancer insurance market statistics, including cancer insurance industry global market size, regional shares, competitors with an cancer insurance market share, detailed cancer insurance market segments, market trends and opportunities, and any further data you may need to thrive in the cancer insurance industry. This cancer insurance market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cancer insurance market size has grown strongly in recent years. It will grow from $70.00 billion in 2023 to $75.67 billion in 2024 at a compound annual growth rate (CAGR) of 8.1%. Historical growth can be traced to rising cancer incidence rates, medical inflation, heightened awareness and education, and potential premium increases reflecting higher treatment costs, economic expansion, governmental policies, and support.

The cancer insurance market size is expected to see strong growth in the next few years. It will grow to $103.76 billion in 2028 at a compound annual growth rate (CAGR) of 8.2%. Projected growth is anticipated due to an aging population, advancements in products and services, economic shifts, healthcare policies and regulations, awareness initiatives, marketing efforts, and the impact of pandemics. Key trends in the forecast period include innovative product developments for broader coverage, customizable policies adapted to personal requirements, integration with health plans or as supplementary options, and technological advancements influencing coverage offerings.

The increasing number of cancer cases is expected to drive the growth of the cancer insurance market in the future. This rise is mainly attributed to factors such as aging populations, lifestyle changes such as tobacco use and unhealthy diets, and environmental elements such as pollution and exposure to carcinogens. Cancer insurance offers financial protection by covering medical expenses and other related costs that regular health insurance may not cover, thus helping individuals cope with the substantial financial burdens associated with cancer treatment. For example, according to the International Agency for Research on Cancer (IARC) and the American Cancer Society (ACS), global cancer cases reached nearly 20 million in 2022, with projections indicating a 77% increase to 35 million annually by 2050. Lung cancer was the most prevalent (12.4%), followed by breast (11.6%) and colorectal cancers (9.6%). Lung cancer also accounted for the most deaths, causing 1.8 million fatalities (18.7%), followed by colorectal (9.3%) and liver cancers (7.8%). Therefore, the rising number of cancer cases is expected to boost the growth of the cancer insurance market.

Key players in the cancer insurance market are focusing on developing innovative insurance products, such as specialized cancer insurance policies tailored for women, to offer personalized coverage for their specific healthcare needs. These policies address the unique medical and financial requirements of female policyholders dealing with a cancer diagnosis, providing them with specialized coverage and assistance. For instance, Elephant.in, an India-based insurance company, introduced a unique cancer insurance policy specifically designed for women in March 2024. This policy aims to provide strong financial security to women facing the significant challenges of cancer diagnosis and treatment, covering the five main types of cancers affecting women-breast, cervical, ovarian, oral, and colorectal. It offers lump sum payouts upon diagnosis of any covered cancer, providing financial support ranging from ₹5,00,000 ($0.5 million) to ₹30,00,000 ($0.3 million).

In March 2024, Osara Health, a U.S.-based healthcare solutions provider, collaborated with Allstate Benefit to offer comprehensive cancer support programs to its policyholders. This partnership represents a significant development in the U.S. health insurance market, aiming to improve the overall cancer care experience for individuals battling cancer. Allstate Benefits, a U.S.-based insurance company specializing in cancer insurance policies, is part of this initiative.

Major companies operating in the cancer insurance market are UnitedHealth Group Incorporated, Ping An Insurance (Group) Company of China Ltd, Cigna Group, Allianz SE, Legal & General Group plc, AXA SA, Aetna Inc, MetLife Inc, Dai-ichi Life Holdings Inc, Munich Re Group, China Pacific Life Insurance Co Ltd, American International Group Inc, Liberty Mutual Insurance Company, China Life Insurance Company Limited, Zurich Insurance Group Ltd, MAPFRE SA, Huaxia Life Insurance Co Ltd, Aegon NV, AFLAC Incorporated, Atlas Cancer Insurance Services Ltd, Unum Group, Prudential plc, Bajaj Finserv Limited, Mutual of Omaha Insurance Company, Sun Life Financial Inc, Saga Plc

North America was the largest region in the cancer insurance market in 2023. The regions covered in the cancer insurance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cancer insurance market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cancer insurance market includes revenues earned by entities by providing services such as lump-sum payments, non-medical expense coverage, support services, and nutritional counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cancer Insurance Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cancer insurance market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cancer insurance ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cancer insurance market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Lung Cancer; Liver Cancer
  • 2) By Insurance Plan: Individual Plan; Supplement Plan; Critical Illness Plan
  • 3) By Distribution Channel: Brokers; Bancassurance; Agents; Direct Sales; Others Distribution Channels
  • 4) By End-user: Adult; Children
  • Companies Mentioned: UnitedHealth Group Incorporated; Ping An Insurance (Group) Company of China Ltd; Cigna Group; Allianz SE; Legal & General Group plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cancer Insurance Market Characteristics

3. Cancer Insurance Market Trends And Strategies

4. Cancer Insurance Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Cancer Insurance Market Size and Growth

  • 5.1. Global Cancer Insurance Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Cancer Insurance Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Cancer Insurance Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cancer Insurance Market Segmentation

  • 6.1. Global Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Lung Cancer
  • Liver Cancer
  • 6.2. Global Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Individual Plan
  • Supplement Plan
  • Critical Illness Plan
  • 6.3. Global Cancer Insurance Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Brokers
  • Bancassurance
  • Agents
  • Direct Sales
  • Others Distribution Channel
  • 6.4. Global Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Adult
  • Children

7. Cancer Insurance Market Regional And Country Analysis

  • 7.1. Global Cancer Insurance Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Cancer Insurance Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cancer Insurance Market

  • 8.1. Asia-Pacific Cancer Insurance Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cancer Insurance Market

  • 9.1. China Cancer Insurance Market Overview
  • 9.2. China Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cancer Insurance Market

  • 10.1. India Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cancer Insurance Market

  • 11.1. Japan Cancer Insurance Market Overview
  • 11.2. Japan Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cancer Insurance Market

  • 12.1. Australia Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cancer Insurance Market

  • 13.1. Indonesia Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cancer Insurance Market

  • 14.1. South Korea Cancer Insurance Market Overview
  • 14.2. South Korea Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cancer Insurance Market

  • 15.1. Western Europe Cancer Insurance Market Overview
  • 15.2. Western Europe Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cancer Insurance Market

  • 16.1. UK Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cancer Insurance Market

  • 17.1. Germany Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cancer Insurance Market

  • 18.1. France Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cancer Insurance Market

  • 19.1. Italy Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cancer Insurance Market

  • 20.1. Spain Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cancer Insurance Market

  • 21.1. Eastern Europe Cancer Insurance Market Overview
  • 21.2. Eastern Europe Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cancer Insurance Market

  • 22.1. Russia Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cancer Insurance Market

  • 23.1. North America Cancer Insurance Market Overview
  • 23.2. North America Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cancer Insurance Market

  • 24.1. USA Cancer Insurance Market Overview
  • 24.2. USA Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cancer Insurance Market

  • 25.1. Canada Cancer Insurance Market Overview
  • 25.2. Canada Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cancer Insurance Market

  • 26.1. South America Cancer Insurance Market Overview
  • 26.2. South America Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cancer Insurance Market

  • 27.1. Brazil Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cancer Insurance Market

  • 28.1. Middle East Cancer Insurance Market Overview
  • 28.2. Middle East Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cancer Insurance Market

  • 29.1. Africa Cancer Insurance Market Overview
  • 29.2. Africa Cancer Insurance Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Cancer Insurance Market, Segmentation By Insurance Plan, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Cancer Insurance Market, Segmentation By End user, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cancer Insurance Market Competitive Landscape And Company Profiles

  • 30.1. Cancer Insurance Market Competitive Landscape
  • 30.2. Cancer Insurance Market Company Profiles
    • 30.2.1. UnitedHealth Group Incorporated
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Ping An Insurance (Group) Company of China Ltd
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Cigna Group
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Allianz SE
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Legal & General Group plc
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Cancer Insurance Market Other Major And Innovative Companies

  • 31.1. AXA SA
  • 31.2. Aetna Inc
  • 31.3. MetLife Inc
  • 31.4. Dai-ichi Life Holdings Inc
  • 31.5. Munich Re Group
  • 31.6. China Pacific Life Insurance Co Ltd
  • 31.7. American International Group Inc
  • 31.8. Liberty Mutual Insurance Company
  • 31.9. China Life Insurance Company Limited
  • 31.10. Zurich Insurance Group Ltd
  • 31.11. MAPFRE SA
  • 31.12. Huaxia Life Insurance Co Ltd
  • 31.13. Aegon NV
  • 31.14. AFLAC Incorporated
  • 31.15. Atlas Cancer Insurance Services Ltd

32. Global Cancer Insurance Market Competitive Benchmarking

33. Global Cancer Insurance Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Cancer Insurance Market

35. Cancer Insurance Market Future Outlook and Potential Analysis

  • 35.1 Cancer Insurance Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Cancer Insurance Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Cancer Insurance Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer